CN Stock MarketDetailed Quotes

603880 Jiangsu Nanfang Medical

Watchlist
  • 3.31
  • -0.11-3.22%
Market Closed May 16 15:00 CST
968.09MMarket Cap-6340P/E (TTM)

Jiangsu Nanfang Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-38.45%139.18M
10.03%600.1M
19.64%470.31M
37.99%352.87M
58.09%226.13M
3.40%545.37M
-3.00%393.09M
-2.54%255.71M
0.96%143.04M
-50.82%527.44M
Operating revenue
-38.45%139.18M
10.03%600.1M
19.64%470.31M
37.99%352.87M
58.09%226.13M
3.40%545.37M
-3.00%393.09M
-2.54%255.71M
0.96%143.04M
-50.82%527.44M
Other operating revenue
----
-26.59%431.51K
----
--77.49K
----
-84.10%587.79K
----
----
----
255.67%3.7M
Total operating cost
-36.45%143.96M
14.90%661.32M
20.34%469.93M
38.70%348.12M
64.45%226.51M
6.83%575.57M
-1.81%390.5M
-1.68%250.99M
3.35%137.74M
-42.43%538.78M
Operating cost
-38.92%121.78M
15.06%544.43M
21.55%398.27M
43.28%297.45M
73.91%199.39M
13.15%473.18M
2.89%327.67M
2.47%207.59M
6.27%114.65M
-41.03%418.19M
Operating tax surcharges
-10.94%1.63M
23.60%6.99M
31.56%5.01M
66.54%3.54M
110.38%1.83M
30.02%5.66M
28.64%3.81M
6.35%2.13M
-2.94%872K
-57.17%4.35M
Operating expense
-4.21%1.75M
7.48%7.73M
-21.15%3.9M
8.79%2.56M
49.92%1.82M
-21.53%7.19M
3.84%4.95M
-24.47%2.35M
-17.58%1.22M
-92.13%9.16M
Administration expense
-15.17%10.82M
6.61%52.22M
22.14%39.73M
44.13%28.16M
35.30%12.76M
-20.75%48.98M
-23.62%32.53M
-31.98%19.54M
-37.89%9.43M
33.66%61.81M
Financial expense
-44.85%1.32M
69.69%21.77M
429.63%2.61M
-64.69%1.6M
-44.38%2.39M
-12.42%12.83M
-112.99%-791.95K
-8.23%4.53M
1,604.59%4.3M
-26.33%14.65M
-Interest expense (Financial expense)
51.11%946.69K
14.92%23.19M
-8.77%7.44M
-23.26%5.3M
-84.03%626.5K
71.01%20.18M
53.44%8.15M
107.42%6.9M
147.90%3.92M
55.30%11.8M
-Interest Income (Financial expense)
43.71%-133.24K
42.49%-1.16M
-106.95%-1.03M
-171.23%-848.96K
-67.12%-236.7K
-73.79%-2.01M
49.89%-496.38K
61.79%-313K
75.57%-141.64K
46.42%-1.16M
Research and development
-19.98%6.65M
1.64%28.18M
-8.68%20.4M
-0.22%14.82M
14.34%8.31M
-9.46%27.73M
-2.14%22.33M
6.74%14.85M
-4.04%7.27M
-9.83%30.62M
Credit Impairment Loss
-91.77%297.59K
-612.43%-38.9M
114.15%645.95K
83.68%-279.59K
864.77%3.62M
-32.63%-5.46M
-237.19%-4.57M
-153.38%-1.71M
63.19%-472.89K
78.89%-4.12M
Asset Impairment Loss
41.61%2.99M
-1,131.16%-56.07M
132.42%113.1K
147.85%294.57K
349.62%2.11M
78.80%-4.55M
-122.54%-348.84K
54.84%-615.62K
--468.91K
19.87%-21.49M
Other net revenue
-30.52%5.77M
-10,300.92%-85.59M
164.23%7.16M
94.02%4.03M
288.46%8.3M
105.02%839.07K
-76.77%2.71M
-68.61%2.08M
371.22%2.14M
52.02%-16.73M
Fair value change income
----
5.73%1.3M
----
----
----
--1.23M
----
----
----
----
Invest income
-1.04%1.99M
8.49%7.99M
3.77%6.18M
4.30%4.05M
3.65%2.01M
-3.69%7.36M
-0.23%5.96M
-6.16%3.88M
24.61%1.94M
-23.84%7.65M
-Including: Investment income associates
-1.04%1.99M
8.37%7.98M
3.77%6.18M
4.30%4.05M
49.08%2.01M
7.35%7.36M
14.94%5.96M
15.94%3.88M
-13.36%1.35M
9.32%6.86M
Asset deal income
----
-17,166.84%-2.9M
-5,480.35%-913.8K
-5,480.35%-913.8K
-154.40%-9.24K
-69.01%16.98K
-69.01%16.98K
-67.58%16.98K
--16.98K
131.72%54.81K
Other revenue
-13.80%497.89K
33.03%2.99M
-31.33%1.13M
73.31%878.57K
208.45%577.63K
91.92%2.25M
115.40%1.65M
-12.22%506.94K
1.83%187.27K
-15.28%1.17M
Operating profit
-87.47%992.61K
-400.08%-146.82M
42.38%7.55M
29.05%8.77M
6.45%7.92M
-4.58%-29.36M
-72.41%5.3M
-50.38%6.8M
-16.09%7.44M
-127.61%-28.07M
Add:Non operating Income
20,573.57%918.89K
-46.86%73.28K
----
----
--4.44K
278,315.26%137.9K
----
----
----
-100.00%49.53
Less:Non operating expense
-20.22%1.19K
1,340.89%1.77M
16.18%151.58K
397.53%151.58K
--1.5K
-95.29%122.91K
-88.96%130.47K
-97.42%30.47K
----
193.89%2.61M
Total profit
-75.89%1.91M
-406.13%-148.52M
43.04%7.39M
27.40%8.62M
6.49%7.92M
4.37%-29.34M
-71.33%5.17M
-45.95%6.77M
-16.08%7.44M
-127.93%-30.69M
Less:Income tax cost
-84.40%157.86K
91.46%-1.23M
94.47%-36.04K
-15.12%661.74K
20.75%1.01M
-88.38%-14.41M
-118.58%-651.86K
-45.36%779.63K
826.85%837.77K
-165.92%-7.65M
Net profit
-74.64%1.75M
FPtoL-147.29M
27.64%7.43M
32.93%7.96M
4.68%6.91M
FPtoL-14.94M
-59.91%5.82M
-46.03%5.99M
-26.49%6.6M
SL-23.04M
Net profit from continuing operation
-74.64%1.75M
-886.01%-147.29M
27.64%7.43M
32.93%7.96M
4.68%6.91M
35.16%-14.94M
-59.91%5.82M
-46.03%5.99M
-26.49%6.6M
-123.44%-23.04M
Less:Minority Profit
137.77%7.35K
144.38%128.31K
149.13%167.37K
124.00%59.7K
84.40%-19.47K
-4.72%-289.13K
-55.19%-340.65K
-105.34%-248.77K
15.19%-124.77K
-227.70%-276.09K
Net profit of parent company owners
-74.82%1.75M
-906.35%-147.42M
17.87%7.26M
26.67%7.9M
3.03%6.93M
35.64%-14.65M
-58.19%6.16M
-44.40%6.24M
-26.31%6.73M
-123.21%-22.76M
Earning per share
Basic earning per share
-75.00%0.006
-920.00%-0.51
19.05%0.025
50.00%0.03
4.35%0.024
37.50%-0.05
-58.00%0.021
-47.37%0.02
-25.81%0.023
-123.35%-0.08
Diluted earning per share
-75.00%0.006
-920.00%-0.51
19.05%0.025
50.00%0.03
4.35%0.024
37.50%-0.05
-58.00%0.021
-47.37%0.02
-25.81%0.023
-123.35%-0.08
Other composite income
-79.88%25.28K
490.29%125.64K
67.01%-32.19K
Other composite income of parent company owners
----
-79.88%25.28K
----
----
----
490.29%125.64K
----
----
----
67.01%-32.19K
Total composite income
-74.64%1.75M
-894.21%-147.26M
27.64%7.43M
32.93%7.96M
4.68%6.91M
35.80%-14.81M
-59.91%5.82M
-46.03%5.99M
-26.49%6.6M
-123.50%-23.07M
Total composite income of parent company owners
-74.82%1.75M
-914.88%-147.39M
17.87%7.26M
26.67%7.9M
3.03%6.93M
36.29%-14.52M
-58.19%6.16M
-44.40%6.24M
-26.31%6.73M
-123.27%-22.79M
Total composite income of minority owners
137.77%7.35K
144.38%128.31K
149.13%167.37K
124.00%59.7K
84.40%-19.47K
-4.72%-289.13K
-55.19%-340.65K
-105.34%-248.77K
15.19%-124.77K
-227.70%-276.09K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Adverse Opinion
--
--
--
Unqualified opinion
Auditor
--
Tianheng Certified Public Accountants (Special General Partnership)
--
--
--
Tianheng Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -38.45%139.18M10.03%600.1M19.64%470.31M37.99%352.87M58.09%226.13M3.40%545.37M-3.00%393.09M-2.54%255.71M0.96%143.04M-50.82%527.44M
Operating revenue -38.45%139.18M10.03%600.1M19.64%470.31M37.99%352.87M58.09%226.13M3.40%545.37M-3.00%393.09M-2.54%255.71M0.96%143.04M-50.82%527.44M
Other operating revenue -----26.59%431.51K------77.49K-----84.10%587.79K------------255.67%3.7M
Total operating cost -36.45%143.96M14.90%661.32M20.34%469.93M38.70%348.12M64.45%226.51M6.83%575.57M-1.81%390.5M-1.68%250.99M3.35%137.74M-42.43%538.78M
Operating cost -38.92%121.78M15.06%544.43M21.55%398.27M43.28%297.45M73.91%199.39M13.15%473.18M2.89%327.67M2.47%207.59M6.27%114.65M-41.03%418.19M
Operating tax surcharges -10.94%1.63M23.60%6.99M31.56%5.01M66.54%3.54M110.38%1.83M30.02%5.66M28.64%3.81M6.35%2.13M-2.94%872K-57.17%4.35M
Operating expense -4.21%1.75M7.48%7.73M-21.15%3.9M8.79%2.56M49.92%1.82M-21.53%7.19M3.84%4.95M-24.47%2.35M-17.58%1.22M-92.13%9.16M
Administration expense -15.17%10.82M6.61%52.22M22.14%39.73M44.13%28.16M35.30%12.76M-20.75%48.98M-23.62%32.53M-31.98%19.54M-37.89%9.43M33.66%61.81M
Financial expense -44.85%1.32M69.69%21.77M429.63%2.61M-64.69%1.6M-44.38%2.39M-12.42%12.83M-112.99%-791.95K-8.23%4.53M1,604.59%4.3M-26.33%14.65M
-Interest expense (Financial expense) 51.11%946.69K14.92%23.19M-8.77%7.44M-23.26%5.3M-84.03%626.5K71.01%20.18M53.44%8.15M107.42%6.9M147.90%3.92M55.30%11.8M
-Interest Income (Financial expense) 43.71%-133.24K42.49%-1.16M-106.95%-1.03M-171.23%-848.96K-67.12%-236.7K-73.79%-2.01M49.89%-496.38K61.79%-313K75.57%-141.64K46.42%-1.16M
Research and development -19.98%6.65M1.64%28.18M-8.68%20.4M-0.22%14.82M14.34%8.31M-9.46%27.73M-2.14%22.33M6.74%14.85M-4.04%7.27M-9.83%30.62M
Credit Impairment Loss -91.77%297.59K-612.43%-38.9M114.15%645.95K83.68%-279.59K864.77%3.62M-32.63%-5.46M-237.19%-4.57M-153.38%-1.71M63.19%-472.89K78.89%-4.12M
Asset Impairment Loss 41.61%2.99M-1,131.16%-56.07M132.42%113.1K147.85%294.57K349.62%2.11M78.80%-4.55M-122.54%-348.84K54.84%-615.62K--468.91K19.87%-21.49M
Other net revenue -30.52%5.77M-10,300.92%-85.59M164.23%7.16M94.02%4.03M288.46%8.3M105.02%839.07K-76.77%2.71M-68.61%2.08M371.22%2.14M52.02%-16.73M
Fair value change income ----5.73%1.3M--------------1.23M----------------
Invest income -1.04%1.99M8.49%7.99M3.77%6.18M4.30%4.05M3.65%2.01M-3.69%7.36M-0.23%5.96M-6.16%3.88M24.61%1.94M-23.84%7.65M
-Including: Investment income associates -1.04%1.99M8.37%7.98M3.77%6.18M4.30%4.05M49.08%2.01M7.35%7.36M14.94%5.96M15.94%3.88M-13.36%1.35M9.32%6.86M
Asset deal income -----17,166.84%-2.9M-5,480.35%-913.8K-5,480.35%-913.8K-154.40%-9.24K-69.01%16.98K-69.01%16.98K-67.58%16.98K--16.98K131.72%54.81K
Other revenue -13.80%497.89K33.03%2.99M-31.33%1.13M73.31%878.57K208.45%577.63K91.92%2.25M115.40%1.65M-12.22%506.94K1.83%187.27K-15.28%1.17M
Operating profit -87.47%992.61K-400.08%-146.82M42.38%7.55M29.05%8.77M6.45%7.92M-4.58%-29.36M-72.41%5.3M-50.38%6.8M-16.09%7.44M-127.61%-28.07M
Add:Non operating Income 20,573.57%918.89K-46.86%73.28K----------4.44K278,315.26%137.9K-------------100.00%49.53
Less:Non operating expense -20.22%1.19K1,340.89%1.77M16.18%151.58K397.53%151.58K--1.5K-95.29%122.91K-88.96%130.47K-97.42%30.47K----193.89%2.61M
Total profit -75.89%1.91M-406.13%-148.52M43.04%7.39M27.40%8.62M6.49%7.92M4.37%-29.34M-71.33%5.17M-45.95%6.77M-16.08%7.44M-127.93%-30.69M
Less:Income tax cost -84.40%157.86K91.46%-1.23M94.47%-36.04K-15.12%661.74K20.75%1.01M-88.38%-14.41M-118.58%-651.86K-45.36%779.63K826.85%837.77K-165.92%-7.65M
Net profit -74.64%1.75MFPtoL-147.29M27.64%7.43M32.93%7.96M4.68%6.91MFPtoL-14.94M-59.91%5.82M-46.03%5.99M-26.49%6.6MSL-23.04M
Net profit from continuing operation -74.64%1.75M-886.01%-147.29M27.64%7.43M32.93%7.96M4.68%6.91M35.16%-14.94M-59.91%5.82M-46.03%5.99M-26.49%6.6M-123.44%-23.04M
Less:Minority Profit 137.77%7.35K144.38%128.31K149.13%167.37K124.00%59.7K84.40%-19.47K-4.72%-289.13K-55.19%-340.65K-105.34%-248.77K15.19%-124.77K-227.70%-276.09K
Net profit of parent company owners -74.82%1.75M-906.35%-147.42M17.87%7.26M26.67%7.9M3.03%6.93M35.64%-14.65M-58.19%6.16M-44.40%6.24M-26.31%6.73M-123.21%-22.76M
Earning per share
Basic earning per share -75.00%0.006-920.00%-0.5119.05%0.02550.00%0.034.35%0.02437.50%-0.05-58.00%0.021-47.37%0.02-25.81%0.023-123.35%-0.08
Diluted earning per share -75.00%0.006-920.00%-0.5119.05%0.02550.00%0.034.35%0.02437.50%-0.05-58.00%0.021-47.37%0.02-25.81%0.023-123.35%-0.08
Other composite income -79.88%25.28K490.29%125.64K67.01%-32.19K
Other composite income of parent company owners -----79.88%25.28K------------490.29%125.64K------------67.01%-32.19K
Total composite income -74.64%1.75M-894.21%-147.26M27.64%7.43M32.93%7.96M4.68%6.91M35.80%-14.81M-59.91%5.82M-46.03%5.99M-26.49%6.6M-123.50%-23.07M
Total composite income of parent company owners -74.82%1.75M-914.88%-147.39M17.87%7.26M26.67%7.9M3.03%6.93M36.29%-14.52M-58.19%6.16M-44.40%6.24M-26.31%6.73M-123.27%-22.79M
Total composite income of minority owners 137.77%7.35K144.38%128.31K149.13%167.37K124.00%59.7K84.40%-19.47K-4.72%-289.13K-55.19%-340.65K-105.34%-248.77K15.19%-124.77K-227.70%-276.09K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Adverse Opinion------Unqualified opinion
Auditor --Tianheng Certified Public Accountants (Special General Partnership)------Tianheng Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg